June 5, 2019
Immunogenicity and Safety of a Quadrivalent Plant-derived Virus Like Particle Influenza Vaccine Candidate – Two Randomized Phase II Clinical Trials in 18 to 49 and ≥50 Years Old Adults
Download publicationInfographics
January 31, 2023
Immune Monitoring
More infoCellTalk Blog
January 31, 2023
Immune Monitoring
More infoCellTalk Blog
December 14, 2022
Immune Monitoring
More info